FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2886906891> ?p ?o ?g. }

• W2886906891 endingPage "844" @default.
• W2886906891 startingPage "831" @default.
• W2886906891 abstract "Treatment of hematological malignancy with antibody-drug conjugates (ADCs) may cause liver injury. ADCs deliver a toxic moiety into antigen-expressing tumor cells, but may also injure hepatic sinusoids (sinusoidal obstruction syndrome; SOS). We studied patients who received an anti-CD22/calicheamicin conjugate (inotuzumab ozogamicin; InO) to gain insight into mechanisms of sinusoidal injury, given that there are no CD22+ cells in the normal liver, but nonspecific uptake of ADCs by liver sinusoidal endothelial cells (LSECs). Six hundred thirty-eight patients (307 with acute lymphocytic leukemia [ALL], 311 with non-Hodgkin's lymphoma [NHL]) were randomized to either InO or standard chemotherapy (controls). While blinded to treatment assignment, we reviewed all cases with hepatobiliary complications to adjudicate the causes. Frequency of SOS among patients who received InO was 5 of 328 (1.5%), compared to no cases among 310 control patients. Drug-induced liver injury (DILI) developed in 26 (7.9%) InO recipients and 3 (1%) controls. Intrahepatic cholestasis (IHC) was observed in 4.9% of InO recipients and in 5.5% of controls. Subsequent to the randomization study, 113 patients with ALL underwent allogeneic hematopoietic cell transplantation (HCT); frequency of SOS in those previously exposed to InO was 21 of 79 (27%) versus 3 of 34 (9%) in controls. An exploratory multivariate model identified a past history of liver disease and thrombocytopenia before conditioning therapy as dominant risk factors for SOS after transplant. Conclusion: Frequencies of SOS and DILI after inotuzumab ozogamicin treatment were 1.5% and 7.9%, respectively, compared to none and 1% among controls who received standard chemotherapy. These data suggest that ADCs that do not target antigens present in the normal liver have a relatively low frequency of SOS, but a relatively high frequency of DILI." @default.
• W2886906891 created "2018-08-22" @default.
• W2886906891 creator A5017236992 @default.
• W2886906891 creator A5032915645 @default.
• W2886906891 creator A5048480496 @default.
• W2886906891 creator A5079191719 @default.
• W2886906891 date "2019-01-18" @default.
• W2886906891 modified "2023-09-25" @default.
• W2886906891 title "Liver Complications Following Treatment of Hematologic Malignancy With Anti‐CD22‐Calicheamicin (Inotuzumab Ozogamicin)" @default.
• W2886906891 cites W15108545 @default.
• W2886906891 cites W1754648675 @default.
• W2886906891 cites W1781806439 @default.
• W2886906891 cites W1965554106 @default.
• W2886906891 cites W1965635980 @default.
• W2886906891 cites W1972172571 @default.
• W2886906891 cites W1983999484 @default.
• W2886906891 cites W1984074063 @default.
• W2886906891 cites W1987935161 @default.
• W2886906891 cites W2011280229 @default.
• W2886906891 cites W2017821630 @default.
• W2886906891 cites W2026710725 @default.
• W2886906891 cites W2033401501 @default.
• W2886906891 cites W2036409356 @default.
• W2886906891 cites W2041273197 @default.
• W2886906891 cites W2054634308 @default.
• W2886906891 cites W2059353285 @default.
• W2886906891 cites W2076106584 @default.
• W2886906891 cites W2080451893 @default.
• W2886906891 cites W2081382604 @default.
• W2886906891 cites W2092006545 @default.
• W2886906891 cites W2119008186 @default.
• W2886906891 cites W2119749845 @default.
• W2886906891 cites W2122712927 @default.
• W2886906891 cites W2137751205 @default.
• W2886906891 cites W2146079375 @default.
• W2886906891 cites W2159562550 @default.
• W2886906891 cites W2166589975 @default.
• W2886906891 cites W2297989334 @default.
• W2886906891 cites W2419639370 @default.
• W2886906891 cites W2525070758 @default.
• W2886906891 cites W2583556164 @default.
• W2886906891 cites W2725925241 @default.
• W2886906891 cites W2730231599 @default.
• W2886906891 cites W2784019442 @default.
• W2886906891 doi "https://doi.org/10.1002/hep.30222" @default.
• W2886906891 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6351187" @default.
• W2886906891 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30120894" @default.
• W2886906891 hasPublicationYear "2019" @default.
• W2886906891 type Work @default.
• W2886906891 sameAs 2886906891 @default.
• W2886906891 citedByCount "29" @default.
• W2886906891 countsByYear W28869068912018 @default.
• W2886906891 countsByYear W28869068912019 @default.
• W2886906891 countsByYear W28869068912020 @default.
• W2886906891 countsByYear W28869068912021 @default.
• W2886906891 countsByYear W28869068912022 @default.
• W2886906891 countsByYear W28869068912023 @default.
• W2886906891 crossrefType "journal-article" @default.
• W2886906891 hasAuthorship W2886906891A5017236992 @default.
• W2886906891 hasAuthorship W2886906891A5032915645 @default.
• W2886906891 hasAuthorship W2886906891A5048480496 @default.
• W2886906891 hasAuthorship W2886906891A5079191719 @default.
• W2886906891 hasBestOaLocation W28869068912 @default.
• W2886906891 hasConcept C111700020 @default.
• W2886906891 hasConcept C126322002 @default.
• W2886906891 hasConcept C18031839 @default.
• W2886906891 hasConcept C2776637226 @default.
• W2886906891 hasConcept C2776694085 @default.
• W2886906891 hasConcept C2776755627 @default.
• W2886906891 hasConcept C2777408962 @default.
• W2886906891 hasConcept C2778245361 @default.
• W2886906891 hasConcept C2778729363 @default.
• W2886906891 hasConcept C2779263901 @default.
• W2886906891 hasConcept C2779338263 @default.
• W2886906891 hasConcept C2779609443 @default.
• W2886906891 hasConcept C2780895475 @default.
• W2886906891 hasConcept C2911091166 @default.
• W2886906891 hasConcept C71924100 @default.
• W2886906891 hasConcept C90924648 @default.
• W2886906891 hasConceptScore W2886906891C111700020 @default.
• W2886906891 hasConceptScore W2886906891C126322002 @default.
• W2886906891 hasConceptScore W2886906891C18031839 @default.
• W2886906891 hasConceptScore W2886906891C2776637226 @default.
• W2886906891 hasConceptScore W2886906891C2776694085 @default.
• W2886906891 hasConceptScore W2886906891C2776755627 @default.
• W2886906891 hasConceptScore W2886906891C2777408962 @default.
• W2886906891 hasConceptScore W2886906891C2778245361 @default.
• W2886906891 hasConceptScore W2886906891C2778729363 @default.
• W2886906891 hasConceptScore W2886906891C2779263901 @default.
• W2886906891 hasConceptScore W2886906891C2779338263 @default.
• W2886906891 hasConceptScore W2886906891C2779609443 @default.
• W2886906891 hasConceptScore W2886906891C2780895475 @default.
• W2886906891 hasConceptScore W2886906891C2911091166 @default.
• W2886906891 hasConceptScore W2886906891C71924100 @default.
• W2886906891 hasConceptScore W2886906891C90924648 @default.
• W2886906891 hasIssue "2" @default.
• W2886906891 hasLocation W28869068911 @default.
• W2886906891 hasLocation W28869068912 @default.

• next